Doping in Sports: From Athletic Violation to Organised Crime — India's Law Reforms

Early History: Pressure, Shortcuts, and Institutional Void

Doping concerns in Indian sports first emerged meaningfully around the 1982 New Delhi Asian Games, when the pressure to win at a home Games, combined with easy availability of substances, led to early documented use of performance-enhancing drugs. By 1986, Indian athletes were testing positive at international events. Between 2009 and 2012, 48 Indian track and field athletes were sanctioned for doping violations. India's record of over 150 violations in 2019 placed it consistently among the global top three worst offenders, even before NADA had matured as an institution. The structural causes were plain: inadequate testing infrastructure, a lack of awareness particularly among rural and first-generation athletes, the pharmaceutical industry's unregulated production of steroids, and governance failures in national sports federations.

Issue 1: India as a Global PED Production Hub

The most structurally significant dimension of India's doping problem is not the athletes who test positive — it is that India is the world's largest manufacturer and exporter of illegal performance-enhancing drugs and anabolic steroids. India's pharmaceutical industry, the third largest globally by volume, produces vast quantities of legitimate medicines. But the same supply chains, raw material networks, and manufacturing infrastructure are exploited for unregulated PED production. Pharmaceutical-grade steroids, growth hormones, and masking agents — banned under WADA's Prohibited List — are produced in underground laboratories and small-scale pharmaceutical units, often using legitimate pharmaceutical raw materials diverted from regulated supply chains. These substances reach athletes directly through coaches, gym trainers, physios, and online marketplaces, often at minimal cost.

Issue 2: Institutional Weaknesses of NADA

Despite being established in 2009 and placed on a statutory footing in 2022, NADA has faced persistent criticism. Before the 2025 Amendment, NADA's operational independence was compromised by government oversight — WADA repeatedly flagged this as non-compliant with the World Anti-Doping Code, which requires NADOs to be independent of government ministries and sports federations. India's Disciplinary Tribunals have been criticised for procedural delays, with dispute resolution taking significantly longer than comparable jurisdictions like Canada or New Zealand. Empirical research confirms that Indian athletes are far less likely to be legally represented in anti-doping proceedings, making the system structurally biased against those who lack resources. As of 2025, the National Dope Testing Laboratory (NDTL) in New Delhi had only recently achieved renewed WADA accreditation after previous suspension — a direct consequence of governance failures.

Issue 3: Awareness Gaps and Inadvertent Doping

A substantial portion of India's positive tests are attributed to inadvertent doping — athletes consuming over-the-counter supplements, locally prescribed medicines, or contaminated nutritional products without knowledge of their WADA-prohibited contents. Studies of elite Indian athletes show that while most have high awareness of the health importance of clean sport, less than 40% have received formal anti-doping education. Many athletes come from small towns and rural backgrounds and are dependent on local coaches or trainers who themselves lack WADA compliance knowledge. The "Know Your Medicine" (KYM) app launched by NADA allows athletes to check whether specific medicines contain prohibited substances — but awareness of this tool remains limited.

Issue 4: Weak Governance of National Sports Federations

Many of India's National Sports Federations (NSFs) have operated with poor governance — financial irregularities, nepotism, undemocratic elections, and inadequate athlete welfare mechanisms. These governance failures directly enable doping. When athletes are not supported with quality scientific training, nutrition, and physiological monitoring, they are more vulnerable to pressure from coaches who suggest pharmacological shortcuts. The IOC has publicly cited NSF governance failures alongside anti-doping violations as two of the three primary obstacles to India's 2036 Olympic bid. The National Sports Governance Bill 2025, passed alongside the Anti-Doping Amendment, directly addresses this by creating the National Sports Board (NSB) with powers to recognise, regulate, and de-recognise NSFs.

The Poverty-Pressure Nexus: Sport as a Route Out

For a large proportion of India's athletes — particularly in rural districts, from agrarian communities, from OBC and Scheduled Caste backgrounds — competitive sport is not merely a vocation but a pathway out of poverty. Government jobs through sports quotas, cash prizes for medals, and the social capital of being a state or national champion represent transformative life outcomes. This structural reality means the pressure to win is not simply competitive ego — it is existential. When a first-generation athlete from a small town in Haryana, UP, or Punjab is given a tablet by their coach and told it is a supplement that will help them make the national team, the ethical calculus is not the same as that of a well-resourced athlete with access to sports scientists and legal advisors. Sociologists of sport argue that doping among athletes from developing countries often reflects systemic vulnerability rather than deliberate cheating. This does not excuse violations — but it demands that policy responses address the structural root causes rather than simply escalating penalties on athletes.

Gender Dimensions of Doping in Indian Sports

Female athletes in India face a compound vulnerability. They are subject to the same strict liability as male athletes, but often have less access to formal anti-doping education, fewer interactions with Doping Control Officers before testing, and are more reliant on coaches for dietary guidance. The power imbalance between female athletes and their coaches — documented extensively in cases of sexual harassment in Indian sports — extends to the domain of doping, where athletes may feel unable to question what a coach recommends for "performance." High-profile cases like the provisional suspension of U-23 wrestling champion and Paris Olympics quarter-finalist Reetika Hooda in July 2025 draw attention to doping in women's wrestling — one of India's most successful sports for female athletes.

Ethical Debate: Punishment vs. Rehabilitation

A core ethical tension in anti-doping policy is whether the objective should be deterrence through punishment or correction through rehabilitation and education. India's historical approach has been almost entirely punitive — bans, public naming, loss of government employment. Critics argue this approach has failed: India's violation numbers have risen year-on-year despite ever-stricter sporting penalties. The proposed shift to criminal prosecution of supply-chain actors is justified on deterrence grounds — but raises the question of proportionality when medical practitioners face imprisonment for prescribing medicines that happen to contain prohibited substances, even where the prescription was clinically appropriate. The proposed 2026 amendments include safeguards for Therapeutic Use Exemptions (TUEs) and protect legitimate medical practitioners — but these carve-outs require careful drafting to avoid both under-inclusion and abuse.

Implication 1: Athlete Health and Long-Term Welfare

The most immediate and personal implication of doping is on athlete health. Performance-enhancing substances — particularly anabolic steroids, EPO, and growth hormones — carry severe long-term health risks: cardiovascular damage (sudden cardiac arrest, irregular heartbeat), hormonal disruption leading to infertility, liver and kidney damage, depression, anxiety, suicidal ideation, and drug dependency. For young Indian athletes, many of whom begin using PEDs in their teens under coach guidance, the health consequences emerge years after competitive careers have ended — and often fall on athletes from backgrounds without health insurance or quality medical support. The Indian sports system's historical failure to provide robust sports medicine, nutrition science, and physiological support has made pharmacological shortcuts not just tempting but structurally incentivised.

Implication 2: India's Olympic Hosting Aspirations

India's anti-doping failures carry direct, existential consequences for its aspirations to host the 2030 Commonwealth Games (Ahmedabad) and bid for the 2036 Olympics (Ahmedabad). The IOC, in high-level meetings with Indian Olympic Association officials in July 2025, explicitly identified anti-doping failures as one of three "showstoppers" that could block India's Olympic bid. The IOC requires a WADA compliance report as part of any host city assessment. ITA (International Testing Agency) Director General Benjamin Cohen stated that India needs "a lot of governance and structural reforms" if it wants to be taken seriously as a 2036 host. Crucially, these sporting mega-events represent not just athletic prestige but enormous economic returns — tourism, infrastructure development, branding, and FDI. India's failure to clean up its sports ecosystem is therefore a direct economic and diplomatic cost.

Implication 3: India's Pharmaceutical Reputation

India's pharmaceutical industry — "Pharmacy of the World" — supplies 20% of global generic medicines. The finding that India is also the world's largest producer of illegal PEDs and steroids creates a serious reputational risk for the legitimate pharmaceutical sector. If global regulatory attention focuses on India's pharmaceutical supply chains in response to doping intelligence, the consequences for export-oriented pharmaceutical firms — whose access to Western markets depends on FDA, EMA, and WHO compliance — could be severe. There is a legitimate policy tension between cracking down on illegal PED production (a law enforcement imperative) and ensuring that regulatory overreach does not damage legitimate pharmaceutical manufacturing, which employs millions and generates over $25 billion annually in exports.

Implication 4: Constitutional Rights Tensions

The proposed criminalisation of supply-chain actors raises constitutional questions. While the government's objective — deterring organised doping networks — is legitimate, the proposed law must navigate carefully between Articles 19(1)(g) (freedom to practise a profession — medical practitioners) and Article 21 (protection against arbitrary deprivation of liberty). The provision making medical practitioners criminally liable for prescribing banned substances, unless protected by TUE, requires precise drafting to ensure that doctors are not criminalised for clinically appropriate prescriptions that incidentally contain prohibited substances. The strict liability principle applied to athletes has already been critiqued for violating natural justice under Article 14; extending criminal liability to supporters creates additional Article 20 (protection against self-incrimination and double jeopardy) considerations.

National Anti-Doping Act 2022: The Statutory Foundation

The National Anti-Doping Act 2022 was India's first statutory anti-doping framework, giving legislative force to India's obligations under the UNESCO International Convention Against Doping in Sport (2005), which India ratified in 2007. Before 2022, NADA existed merely as a registered society — with no statutory powers, no mandatory compliance mechanisms, and no enforceable authority over sports bodies that chose not to co-operate. The 2022 Act placed NADA on a statutory footing, established the National Anti-Doping Agency with defined powers, created the National Dope Testing Laboratory as the primary testing facility, established a Disciplinary Panel for adjudication of violations, and created the National Board for Anti-Doping in Sports to oversee NADA and advise the government. Critically, however, the government at that stage rejected criminal provisions for suppliers, opting for a purely administrative/sporting enforcement mechanism.

National Anti-Doping (Amendment) Bill 2025: Key Changes

Introduced in Lok Sabha on July 23, 2025, and passed by both Houses on August 12, 2025, the Amendment made several critical changes that directly responded to WADA's compliance concerns. The most significant was the grant of full operational autonomy to NADA — removing government interference in day-to-day operations and independence from both government ministries and sports bodies like the IOA and Paralympic bodies. This had been WADA's core demand for years: under the 2022 Act, government oversight made India's anti-doping system technically non-compliant with the WADA Code's independence requirements.

Second, all dope testing laboratories in India are now required to obtain and maintain WADA accreditation — ensuring that test results are scientifically reliable and internationally acceptable. Third, the WADA Code's Article 2 (defining anti-doping rule violations) was incorporated as a statutory Schedule with the force of law, ensuring India's definition of violations remains dynamically aligned with evolving global standards without requiring fresh legislation for each WADA Code update. Fourth, WADA was empowered to file a direct appeal before CAS if no other party has already appealed a final NADA decision — closing a significant enforcement gap.

Technology and Preventive Initiatives

Alongside legislative reform, NADA has deployed technological tools. The NIDAMS Portal (NADA India Data Administration and Management System), launched in 2025, digitalises the entire testing process — from planning tests and generating mission orders for Doping Control Officers to recording results and managing appeals. The Know Your Medicine (KYM) App allows athletes to scan or search medicines to verify whether they contain WADA-prohibited substances — directly addressing the inadvertent doping problem. The Athlete Biological Passport Management Unit (APMU) at NDTL, inaugurated in 2025, enables longitudinal monitoring of athletes' biological markers across career — capable of detecting microdosing and other sophisticated doping that standard in-competition tests miss. NADA also launched nationwide awareness campaigns and a dedicated NADA INDIA app for athlete education.

The Policy Shift: Why Now?

On May 21, 2026, the Ministry of Youth Affairs and Sports released proposed criminal amendments to the National Anti-Doping Act 2022 for public consultation, with a deadline of June 18, 2026, and plans to table the Bill in the Monsoon Session of Parliament. The timing is significant: it follows directly from the WADA GAIIN Conference in New Delhi (April 2026), where WADA's president publicly identified India as the world's largest PED producer and met with India's CBI Director General. The government explicitly stated the objective: to move enforcement from "targeting only athletes who test positive" to targeting "the growing organised ecosystem" of traffickers, illegal suppliers, organised syndicates, coaches, support personnel, and commercial operators.

Sports Minister Mandaviya articulated the logic plainly: "We only punish those who are consuming, but suppliers need to be targeted as well. So whether it is a coach, a manager, a fellow athlete or anyone who has direct access to an athlete, those found guilty of being part of the supply chain will be prosecuted." This represents a complete reversal of the position taken when the 2022 Act was passed — when criminal provisions were deliberately removed in favour of "preventive legislation."

Safeguards and Protections Built Into the Proposal

The Ministry has been careful to build in safeguards that distinguish between legitimate medical practice and criminal doping facilitation. Therapeutic Use Exemptions (TUEs) — formal approvals granted to athletes who need to take a prohibited substance for genuine medical reasons — are explicitly protected. Athletes with valid TUEs cannot be prosecuted for having those substances in their bodies, and medical practitioners prescribing substances covered by a valid TUE are similarly protected. The proposal also explicitly distinguishes between medical practitioners who prescribe banned drugs for legitimate clinical purposes and those who are "willing participants" in doping — only the latter face criminal liability. Athletes themselves are not subject to criminal prosecution merely for testing positive or committing anti-doping rule violations, unless they are found directly involved in criminal supply-chain offences.

The USA: Rodchenkov Anti-Doping Act (RADA) 2020 — The Criminal Law Model

The United States enacted the Rodchenkov Anti-Doping Act (RADA) in December 2020 — named after whistleblower Grigory Rodchenkov, the Moscow laboratory director who exposed Russia's state-sponsored doping programme at the 2014 Sochi Winter Olympics. RADA criminalises international doping conspiracies at events involving US athletes, sponsors, or broadcasters, with penalties of up to 10 years imprisonment and $1 million fines — the most stringent in the world. RADA is significant for India because it represents the model India is partially drawing upon: shifting criminal liability from athletes to those orchestrating doping schemes. However, RADA drew criticism from WADA itself — which expressed concern that unilateral US criminal jurisdiction over global doping activity would "undermine clean sport by jeopardising critical partnerships." India's proposed 5-year provision is measured compared to RADA's 10 years, and — unlike RADA — is framed as domestic rather than extraterritorial legislation.

Russia: State-Sponsored Doping and the Limits of Institutional Reform

Russia's doping scandal — a state-directed, institutionally orchestrated programme that manipulated sample collection at the Sochi 2014 Winter Olympics — represents the extreme end of what organised doping looks like at a governmental level. The systematic substitution of positive samples through a "mouse hole" in the laboratory wall, operated with FSB (state security) support, revealed that doping infrastructure can be embedded in state institutions. Russia's RUSADA was declared non-compliant by WADA; Russian athletes competed at subsequent Olympics under neutral flags. This case is analytically relevant for India: while India's doping problem is not state-directed, the scale and systemic nature of illegal PED production suggests a comparable degree of organised infrastructure, even if commercially rather than politically motivated.

WADA-GAIIN: International Investigation Collaboration

The Global Anti-Doping Intelligence and Investigations Network (GAIIN), led by WADA, is a multinational law enforcement cooperation programme involving over 20 countries working to seize illegal PEDs at a transnational level. To date, GAIIN has dismantled 88 illegal laboratories and seized approximately 90 tonnes of performance-enhancing drugs. India's inclusion in GAIIN cooperation — formalised through WADA's engagement with India's CBI — is a recognition that India's illegal PED production has global consequences: Indian-produced steroids and PEDs enter international supply chains reaching athletes in Europe, Africa, and the Middle East. GAIIN's approach is precisely the model India's proposed criminal law should integrate with — intelligence-led enforcement targeting manufacturing and distribution nodes rather than end-consumer athletes.